Cargando…
Pembrolizumab-Induced Delayed-Onset Hepatitis
Hepatitis is one of the serious immune-related adverse events (irAEs). However, delayed-onset hepatitis induced by immune-checkpoint inhibitors (ICIs) is rare, and the histopathological features remain to be clarified. A 65-year-old woman with advanced lung adenocarcinoma in the right upper lobe (cT...
Autores principales: | Kanaoka, Kensuke, Moriizumi, Kazunori, Okada, Hideyasu, Iwahashi, Kiyoshi, Tsuji, Hiromi, Yasuoka, Hironao, Minami, Seigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670324/ https://www.ncbi.nlm.nih.gov/pubmed/33250701 http://dx.doi.org/10.1159/000509953 |
Ejemplares similares
-
Pembrolizumab-Induced Meningoencephalitis: A Brain Autopsy Case
por: Minami, Seigo, et al.
Publicado: (2021) -
Durvalumab-Induced Diffuse Alveolar Hemorrhage: An Autopsy Case Report
por: Kanaoka, Kensuke, et al.
Publicado: (2020) -
Secondary organizing pneumonia after coronavirus disease 2019: Two cases
por: Kanaoka, Kensuke, et al.
Publicado: (2021) -
Pembrolizumab Treatment-Induced Liver Toxicity
por: Calderon, Benoît, et al.
Publicado: (2021) -
Pulmonary Adenosquamous Cell Carcinoma With Systemic Lymphadenopathy due to Immunoglobulin G4-Related Disease: A Case Report
por: Ikebe, Saori, et al.
Publicado: (2021)